BIKTARVY 50 mg/200 mg/25 mg, film-coated tablet 30 tablets, CIP 3400930153031
Active ingredients: Bictegravir, Bictegravir sodium, Emtricitabine, Tenofovir alafenamide fumarate, Tenofovir alafenamide
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tablets, CIP 3400930153031orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BIKTARVY 50 mg/200 mg/25 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 1 flacon polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimés
- Marketing authorisation holder
- GILEAD SCIENCES IRELAND UC (IRLANDE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 9 Nov 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62844771CIP73015303CIP133400930153031Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| EMTRICITABINEcomprimé | 200 mg · un comprimé | SA |
| FUMARATE DE TÉNOFOVIR ALAFÉNAMIDEcomprimé | — | SA |
| BICTÉGRAVIRcomprimé | 50 mg · un comprimé | FT |
| TÉNOFOVIR ALAFÉNAMIDEcomprimé | 25 mg · un comprimé | FT |
| BICTÉGRAVIR SODIQUEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.